CDIO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
3.6K
-33.0%
5.4K
+100.0%
2.7K
-24.6%
3.6K
+24.5%
2.9K
Cost of Revenue
0
0
0
0
0
Gross Profit
3.6K
-33.0%
5.4K
+100.0%
2.7K
-24.6%
3.6K
+24.5%
2.9K
Operating Expenses
1.7M
+15.3%
1.5M
-15.9%
1.8M
+21.9%
1.5M
-14.4%
1.7M
R&D
174.3K
+6.9%
162.9K
+25.5%
129.8K
-79.8%
641.2K
+239.2%
189.0K
SG&A
1.6M
+16.4%
1.3M
-19.2%
1.7M
+117.3%
760.3K
-50.0%
1.5M
Operating Income
-1730159
-15.5%
-1498147
+16.1%
-1784837
-22.0%
-1463222
+14.5%
-1711597
EBITDA
-1633635
-16.5%
-1402706
+17.0%
-1690185
-23.4%
-1369145
+15.6%
-1622009
Net Income
-1732331
-15.4%
-1501468
+16.0%
-1788158
-22.0%
-1465368
+14.5%
-1714536
EPS (Basic)
$-0.59
-15.7%
$-0.51
+19.0%
$-0.63
+21.3%
$-0.80
+18.4%
$-0.98
EPS (Diluted)
$-0.59
-15.7%
$-0.51
+19.0%
$-0.63
+21.3%
$-0.80
+18.4%
$-0.98
Shares (Diluted)
3.0M
+0.0%
3.0M
+4.2%
2.8M
+55.9%
1.8M
+3.7%
1.8M
Cardio Diagnostics (CDIO) — Financials